MetLife, Inc. 2024 Q3 10-Q Filing Summary
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended September 30, 2024. MetLife, Inc. is a leading global financial services company providing insurance, annuities, employee benefits, and asset management. The company operates through six segments: Group Benefits, Retirement and Income Solutions (RIS), Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. The financial statements are unaudited and reflect all adjustments necessary for fair presentation under GAAP.
Key Financial Metrics
| Metric (in millions) | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Total Revenues | $18,440 | $15,866 | $52,320 | $47,877 |
| Net Income (Loss) | $1,341 | $495 | $3,169 | $988 |
| Net Income Available to Common Shareholders | $1,275 | $422 | $2,987 | $806 |
| Diluted EPS | $1.81 | $0.56 | $4.17 | $1.05 |
| Adjusted Earnings | $1,442 | $1,555 | $4,505 | $4,329 |
| Total Assets | $704,976 | $687,584 | - | - |
| Cash and Cash Equivalents | $21,765 | $20,639 | - | - |
| Long-term Debt | $15,278 | $15,548 | - | - |
Material Changes vs. Prior Period
- Net Income Surge: Net income available to common shareholders increased by $853 million (202%) for Q3 2024 compared to Q3 2023. This was primarily driven by a favorable change of $850 million in net investment gains (losses) and a $2.0 billion favorable change in net derivative gains (losses).
- Derivative Performance: Net derivative gains improved significantly due to decreased long-term interest rates (favorable to receiver swaps) and the weakening of the U.S. dollar against the Japanese yen.
- Investment Gains: Net investment gains improved due to lower impairment losses compared to the prior period (which included losses related to a reinsurance transaction and the pending disposition of MetLife Malaysia) and gains on foreign currency transactions.
- Market Risk Benefits (MRB): MRB remeasurement losses increased by $1.3 billion compared to the prior period, primarily due to decreased long-term interest rates.
- Effective Tax Rate: The effective tax rate for Q3 2024 was 33%, compared to 7% in Q3 2023. The increase was due to foreign earnings taxed at higher statutory rates and the impact of tax equity investments under the proportional amortization method.
Guidance, Outlook, and Risks
- Outlook: Management continues to monitor global inflation, supply chain disruptions, and banking sector volatility. The Federal Open Market Committee (FOMC) lowered interest rates in September 2024, with forecasts suggesting further reductions through 2025.
- Capital Actions: MetLife repurchased $2.8 billion of common stock in the first nine months of 2024. As of September 30, 2024, $2.3 billion remained under the May 2024 repurchase authorization.
- Key Risks:
- Interest Rate Risk: Changes in interest rates significantly impact investment income, policyholder liabilities, and derivative valuations.
- Market Volatility: Equity market fluctuations affect investment returns and the fair value of market risk benefits.
- Regulatory Environment: Ongoing changes in insurance regulation, including the NAIC's modeling of CLOs and new SEC climate disclosure rules (currently stayed pending judicial review).
- Legal Proceedings: Significant litigation includes asbestos-related claims (estimated reasonably possible loss range of $0 to $125 million in excess of accruals) and a False Claims Act action regarding unclaimed property reports.
Investor Verification Checklist
- Derivative Valuations: Verify the sensitivity of net derivative gains to interest rate and currency fluctuations, which drove a significant portion of the Q3 earnings increase.
- Investment Portfolio Quality: Review the allowance for credit losses (ACL) on mortgage loans and fixed maturity securities, particularly in the commercial and agricultural segments.
- MetLife Malaysia Disposition: Monitor the status of the pending sale of MetLife Malaysia, expected to close in the first half of 2025, and its impact on future earnings.
- Actuarial Assumptions: Assess the impact of recent actuarial assumption reviews on future policy benefits and market risk benefits, particularly regarding mortality and morbidity.
- Liquidity Position: Confirm the adequacy of short-term liquidity ($20.2 billion) and liquid assets ($182.7 billion) to meet obligations under stress scenarios.